Last 12 months
Inside the activity.
0 purchase rows · 91 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 50 |
| Feb 2026 | 0 | 21 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 6 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2017 Filed Nov 17, 2017 21:24 UTC |
PELISSON GillesDirector
|
GrantClass A ordinary shares | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000479 · wf-form4_151095385076028.xml · nonDerivative · entry 1 PELISSON Gilles · CIK 0001549025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,114 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:24 UTC |
CLARK RICHARD PChief Accounting Officer
|
Tax withholdingClass A ordinary shares | 19 | $144.34 | $2,742.41 |
DisclosureSEC source: 0001467373-17-000478 · wf-form4_151095383242884.xml · nonDerivative · entry 2 CLARK RICHARD P · CIK 0001583916 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,436 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:24 UTC |
CLARK RICHARD PChief Accounting Officer
|
GrantClass A ordinary shares | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000478 · wf-form4_151095383242884.xml · nonDerivative · entry 1 CLARK RICHARD P · CIK 0001583916 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,455 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC |
MAGNER MARJORIEDirector
|
GrantClass A ordinary shares | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000477 · wf-form4_151095381287270.xml · nonDerivative · entry 1 MAGNER MARJORIE · CIK 0001225173 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,565 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
Tax withholdingClass A ordinary shares | 47 | $144.34 | $6,783.86 |
DisclosureSEC source: 0001467373-17-000476 · wf-form4_151095379336550.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,531 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
GrantClass A ordinary shares | 187 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000476 · wf-form4_151095379336550.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,578 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC |
Nanterme PierreDirector · Chairman & CEO
|
Tax withholdingClass A ordinary shares | 134 | $144.34 | $19,341.23 |
DisclosureSEC source: 0001467373-17-000475 · wf-form4_151095377604221.xml · nonDerivative · entry 2 Nanterme Pierre · CIK 0001411699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,722 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:23 UTC |
Nanterme PierreDirector · Chairman & CEO
|
GrantClass A ordinary shares | 1,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000475 · wf-form4_151095377604221.xml · nonDerivative · entry 1 Nanterme Pierre · CIK 0001411699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,856 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:22 UTC |
Jerdee Chad TGeneral Counsel and CCO
|
Tax withholdingClass A ordinary shares | 13 | $144.34 | $1,876.39 |
DisclosureSEC source: 0001467373-17-000474 · wf-form4_151095375656816.xml · nonDerivative · entry 2 Jerdee Chad T · CIK 0001643685 · General Counsel and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,133 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:22 UTC |
Jerdee Chad TGeneral Counsel and CCO
|
GrantClass A ordinary shares | 108 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000474 · wf-form4_151095375656816.xml · nonDerivative · entry 1 Jerdee Chad T · CIK 0001643685 · General Counsel and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,146 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:22 UTC |
McKinstry NancyDirector
|
GrantClass A ordinary shares | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000473 · wf-form4_151095373872734.xml · nonDerivative · entry 1 McKinstry Nancy · CIK 0001294731 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:21 UTC |
Lumb RichardGroup Chief Executive-Fin Serv
|
Tax withholdingClass A ordinary shares | 89 | $144.34 | $12,846.04 |
DisclosureSEC source: 0001467373-17-000471 · wf-form4_151095370350302.xml · nonDerivative · entry 2 Lumb Richard · CIK 0001506719 · Group Chief Executive-Fin Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,277 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:21 UTC |
Lumb RichardGroup Chief Executive-Fin Serv
|
GrantClass A ordinary shares | 261 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000471 · wf-form4_151095370350302.xml · nonDerivative · entry 1 Lumb Richard · CIK 0001506719 · Group Chief Executive-Fin Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,366 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:21 UTC |
van 't Noordende Alexander MGroup Chief Exec-Products
|
Tax withholdingClass A ordinary shares | 105 | $144.34 | $15,155.44 |
DisclosureSEC source: 0001467373-17-000470 · wf-form4_151095368648392.xml · nonDerivative · entry 2 van 't Noordende Alexander M · CIK 0001374790 · Group Chief Exec-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,476 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:21 UTC |
van 't Noordende Alexander MGroup Chief Exec-Products
|
GrantClass A ordinary shares | 296 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000470 · wf-form4_151095368648392.xml · nonDerivative · entry 1 van 't Noordende Alexander M · CIK 0001374790 · Group Chief Exec-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,581 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:21 UTC |
Tang Frank KuiDirector
|
GrantClass A ordinary shares | 24 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000468 · wf-form4_151095365264094.xml · nonDerivative · entry 1 Tang Frank Kui · CIK 0001607964 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,853 F1 · security: Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:22 UTC |
Shook EllynChief Leadership & HR Officer
|
GrantClass A ordinary shares | 170 | $143.90 | $24,462.15 |
DisclosureSEC source: 0001467373-17-000465 · wf-form4_151008973874639.xml · nonDerivative · entry 1 Shook Ellyn · CIK 0001600370 · Chief Leadership & HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,035 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:22 UTC |
Sweet Julie SpellmanGroup Chief Exec-North America
|
GrantClass A ordinary shares | 99 | $143.90 | $14,245.61 |
DisclosureSEC source: 0001467373-17-000466 · wf-form4_151008975566818.xml · nonDerivative · entry 1 Sweet Julie Spellman · CIK 0001487630 · Group Chief Exec-North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,509 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:23 UTC |
van 't Noordende Alexander MGroup Chief Exec-Products
|
GrantClass A ordinary shares | 198 | $143.90 | $28,491.21 |
DisclosureSEC source: 0001467373-17-000467 · wf-form4_151008977562842.xml · nonDerivative · entry 1 van 't Noordende Alexander M · CIK 0001374790 · Group Chief Exec-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,285 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:21 UTC |
Lumb RichardGroup Chief Executive-Fin Serv
|
GrantClass A ordinary shares | 155 | $143.90 | $22,303.73 |
DisclosureSEC source: 0001467373-17-000463 · wf-form4_151008970270019.xml · nonDerivative · entry 1 Lumb Richard · CIK 0001506719 · Group Chief Executive-Fin Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,105 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:22 UTC |
Sell Robert EGrp Chief Exec-Com, Med & Tech
|
GrantClass A ordinary shares | 62 | $143.90 | $8,921.49 |
DisclosureSEC source: 0001467373-17-000464 · wf-form4_151008971953600.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,495 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:21 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
GrantClass A ordinary shares | 182 | $143.90 | $26,188.89 |
DisclosureSEC source: 0001467373-17-000462 · wf-form4_151008965469664.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,391 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:20 UTC |
Jerdee Chad TGeneral Counsel and CCO
|
GrantClass A ordinary shares | 113 | $143.90 | $16,260.14 |
DisclosureSEC source: 0001467373-17-000461 · wf-form4_151008963391533.xml · nonDerivative · entry 1 Jerdee Chad T · CIK 0001643685 · General Counsel and CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,038 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Voluntary Equity Investment Program. Read SEC document |
| November 05, 2017 Filed Nov 7, 2017 21:20 UTC |
CLARK RICHARD PChief Accounting Officer
|
GrantClass A ordinary shares | 142 | $143.90 | $20,433.09 |
DisclosureSEC source: 0001467373-17-000460 · wf-form4_151008961729914.xml · nonDerivative · entry 1 CLARK RICHARD P · CIK 0001583916 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,375 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program. Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 20:25 UTC |
Casati GianfrancoGroup Chief Exec-Growth Mkts
|
SaleClass A ordinary shares | 20,380 | $142.72 | $2,908,554.12 |
DisclosureSEC source: 0001467373-17-000459 · wf-form4_150956782151825.xml · nonDerivative · entry 1 Casati Gianfranco · CIK 0001374850 · Group Chief Exec-Growth Mkts 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,014 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $142.31 to $143.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 20:26 UTC |
CLARK RICHARD PChief Accounting Officer
|
SaleClass A ordinary shares | 300 | $143.35 | $43,005.00 |
DisclosureSEC source: 0001467373-17-000457 · wf-form4_150939518495058.xml · nonDerivative · entry 2 CLARK RICHARD P · CIK 0001583916 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,233 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $143.32 to $143.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 20:26 UTC |
CLARK RICHARD PChief Accounting Officer
|
SaleClass A ordinary shares | 2,855 | $142.98 | $408,200.48 |
DisclosureSEC source: 0001467373-17-000457 · wf-form4_150939518495058.xml · nonDerivative · entry 1 CLARK RICHARD P · CIK 0001583916 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,533 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $142.29 to $143.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
Shook EllynChief Leadership & HR Officer
|
Tax withholdingClass A ordinary shares | 4,569 | $139.95 | $639,431.55 |
DisclosureSEC source: 0001467373-17-000454 · wf-form4_150913604958376.xml · nonDerivative · entry 2 Shook Ellyn · CIK 0001600370 · Chief Leadership & HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,865 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
Shook EllynChief Leadership & HR Officer
|
GrantClass A ordinary shares | 10,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000454 · wf-form4_150913604958376.xml · nonDerivative · entry 1 Shook Ellyn · CIK 0001600370 · Chief Leadership & HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,434 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
Sweet Julie SpellmanGroup Chief Exec-North America
|
Tax withholdingClass A ordinary shares | 10,375 | $139.95 | $1,451,981.25 |
DisclosureSEC source: 0001467373-17-000455 · wf-form4_150913606520540.xml · nonDerivative · entry 2 Sweet Julie Spellman · CIK 0001487630 · Group Chief Exec-North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,410 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
Sweet Julie SpellmanGroup Chief Exec-North America
|
GrantClass A ordinary shares | 20,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000455 · wf-form4_150913606520540.xml · nonDerivative · entry 1 Sweet Julie Spellman · CIK 0001487630 · Group Chief Exec-North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,785 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 16:25 UTC |
Deblaere JohanChief Operating Officer
|
Tax withholdingClass A ordinary shares | 1,566 | $139.95 | $219,161.70 |
DisclosureSEC source: 0001467373-17-000446 · wf-form4_150913590842997.xml · nonDerivative · entry 2 Deblaere Johan · CIK 0001471431 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,221 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 16:25 UTC |
Deblaere JohanChief Operating Officer
|
GrantClass A ordinary shares | 11,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000446 · wf-form4_150913590842997.xml · nonDerivative · entry 1 Deblaere Johan · CIK 0001471431 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,787 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:28 UTC |
van 't Noordende Alexander MGroup Chief Exec-Products
|
Tax withholdingClass A ordinary shares | 11,379 | $139.95 | $1,592,491.05 |
DisclosureSEC source: 0001467373-17-000456 · wf-form4_150913608126435.xml · nonDerivative · entry 2 van 't Noordende Alexander M · CIK 0001374790 · Group Chief Exec-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,087 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:28 UTC |
van 't Noordende Alexander MGroup Chief Exec-Products
|
GrantClass A ordinary shares | 20,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000456 · wf-form4_150913608126435.xml · nonDerivative · entry 1 van 't Noordende Alexander M · CIK 0001374790 · Group Chief Exec-Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,466 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
Sell Robert EGrp Chief Exec-Com, Med & Tech
|
Tax withholdingClass A ordinary shares | 6,170 | $139.95 | $863,491.50 |
DisclosureSEC source: 0001467373-17-000453 · wf-form4_150913603431364.xml · nonDerivative · entry 2 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,433 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
Sell Robert EGrp Chief Exec-Com, Med & Tech
|
GrantClass A ordinary shares | 11,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000453 · wf-form4_150913603431364.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,603 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
Ollagnier Jean-MarcGroup Chief Exec-Resources
|
Tax withholdingClass A ordinary shares | 1,320 | $139.95 | $184,734.00 |
DisclosureSEC source: 0001467373-17-000451 · wf-form4_150913600006865.xml · nonDerivative · entry 2 Ollagnier Jean-Marc · CIK 0001514393 · Group Chief Exec-Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,740 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
Ollagnier Jean-MarcGroup Chief Exec-Resources
|
GrantClass A ordinary shares | 11,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000451 · wf-form4_150913600006865.xml · nonDerivative · entry 1 Ollagnier Jean-Marc · CIK 0001514393 · Group Chief Exec-Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,060 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
ROWLAND DAVID PChief Financial Officer
|
Tax withholdingClass A ordinary shares | 10,743 | $139.95 | $1,503,482.85 |
DisclosureSEC source: 0001467373-17-000452 · wf-form4_150913601791922.xml · nonDerivative · entry 2 ROWLAND DAVID · CIK 0001580655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,088 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:27 UTC |
ROWLAND DAVID PChief Financial Officer
|
GrantClass A ordinary shares | 22,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000452 · wf-form4_150913601791922.xml · nonDerivative · entry 1 ROWLAND DAVID · CIK 0001580655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,831 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
Nanterme PierreDirector · Chairman & CEO
|
Tax withholdingClass A ordinary shares | 14,519 | $139.95 | $2,031,934.05 |
DisclosureSEC source: 0001467373-17-000450 · wf-form4_150913598424030.xml · nonDerivative · entry 2 Nanterme Pierre · CIK 0001411699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,639 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
Nanterme PierreDirector · Chairman & CEO
|
GrantClass A ordinary shares | 131,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000450 · wf-form4_150913598424030.xml · nonDerivative · entry 1 Nanterme Pierre · CIK 0001411699 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,158 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
Lumb RichardGroup Chief Executive-Fin Serv
|
Tax withholdingClass A ordinary shares | 9,581 | $139.95 | $1,340,860.95 |
DisclosureSEC source: 0001467373-17-000449 · wf-form4_150913596541350.xml · nonDerivative · entry 4 Lumb Richard · CIK 0001506719 · Group Chief Executive-Fin Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,950 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
Lumb RichardGroup Chief Executive-Fin Serv
|
GrantClass A ordinary shares | 20,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000449 · wf-form4_150913596541350.xml · nonDerivative · entry 3 Lumb Richard · CIK 0001506719 · Group Chief Executive-Fin Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,531 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
Tax withholdingClass A ordinary shares | 4,698 | $139.95 | $657,485.10 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 5 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,209 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
GrantClass A ordinary shares | 10,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 4 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,907 Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
SaleClass A ordinary shares | 85 | $140.96 | $11,981.60 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 3 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,554 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
SaleClass A ordinary shares | 1,602 | $140.26 | $224,688.67 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 2 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,639 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F3 · price: The transaction was executed in multiple trades at prices ranging from $139.88 to $140.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 25, 2017 Filed Oct 27, 2017 20:26 UTC |
LONDON DANIEL TGroup Chief Exec - Health & PS
|
SaleClass A ordinary shares | 1,400 | $139.75 | $195,650.00 |
DisclosureSEC source: 0001467373-17-000448 · wf-form4_150913594710095.xml · nonDerivative · entry 1 LONDON DANIEL T · CIK 0001609241 · Group Chief Exec - Health & PS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,241 F1 · kind: Planned disposition of Accenture plc Class A ordinary shares pursuant to a Rule 10b5-1 Trading Plan. F2 · price: The transaction was executed in multiple trades at prices ranging from $138.87 to $139.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.